Revive Therapeutics Ltd. Stock Price - RVVTF

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Revive Therapeutics Ltd. (QB) RVVTF OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.003 -12.35% 0.0213 0.0213 0.0179 0.02 0.0243 16:29:05
Bid Price Ask Price Spread Spread % News
0.013 0.03 0.017 56.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 21,000 $ 0.018821 $ 395 6,667 0.0179 - 0.136
Last Trade Time Type Quantity Stock Price Currency
14:51:57 18,720 $ 0.0213 USD

Revive Therapeutics Ltd. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.54M 72.41M $ -1.79M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
298.00 $ - 0.00% - -

more financials information »

Revive Therapeutics Ltd. News

Loading Messages....

Latest RVVTF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVVTF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.025050.03270.01790.026285916,523-0.00375-14.97%
1 Month0.04110.04110.01790.023743820,470-0.0198-48.18%
3 Months0.038550.050.01790.030656814,524-0.01725-44.75%
6 Months0.095220.095220.01790.037211410,975-0.07392-77.63%
1 Year0.11710.1360.01790.073269513,606-0.0958-81.81%
3 Years0.06650.39820.01790.191709935,498-0.0452-67.97%
5 Years0.52480.550.01790.187855634,789-0.5035-95.94%

Revive Therapeutics Ltd. Description

Revive Therapeutics Ltd. (CSE: RVV) (OTCQB: RVVTF) is a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products. The Company's novel cannabinoid delivery technology is being advanced to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Revive's cannabinoid pharmaceutical portfolio focuses on rare inflammatory and liver diseases. For more information, visit

Your Recent History
Revive The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.